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Improved Risk Assessment
for Abdominal Aortic
Aneurysm Rupture
Off-the-Wall Imaging*
Thomas A. Hope, MD, Michael D. Hope, MD
San Francisco, California
Vessel dimensions are currently the primary imaging pa-
rameter used to risk-stratify patients with abdominal aortic
aneurysms (AAAs). Intervention is recommended for an
AAA with a diameter 5.5 cm. But there is more to the
story. Both the stresses experienced by the aortic wall and
the intrinsic strength of the wall itself are crucial in
predicting rupture. New developments in imaging enable
the direct evaluation of these factors and allow a more
complete, patient-specific assessment of risk for disease
progression.
See page 2522
Hemodynamic parameters derived from imaging are an
attractive means of characterizing the status of the aortic
wall. Abnormal wall shear stress, or the frictional force that
blood flow exerts on the vessel wall, can be estimated from
near wall velocity gradients captured by phase-contrast
magnetic resonance imaging. Studies have shown that low
wall shear stress causes endothelial dysfunction and the
development of atherosclerosis (1). However, because sig-
nificant intraluminal thrombus is often present, the impor-
tance of wall shear stress is confounded in later stages of
aneurysm growth (2). Therefore, instead of measuring wall
shear stress, the focus for the abdominal aorta is wall stress,
the internal force within the vessel wall. Studies of wall
stress have shown good predictive value for AAA rupture,
but they are limited in practice because they require exten-
sive and time-consuming computer modeling (3,4).
The 2 major components of the vessel wall are collagen
and elastin, with decreased collagen thought to be associated
with rupture whereas decreased elastin is associated with
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parameter, reflects the stiffness of the aorta (6) and likely
measures atherosclerotic-related decreases in elastin (7).
owever, collagen is the critical component of the vessel
all that contributes to stability; its degradation and turn-
ver lead to growth and rupture. In pathological specimens,
ncreased levels of collagen breakdown products are seen in
uptured aneurysm (8), but collagen levels are higher in
AA tissue (9). The reason for this counterintuitive finding
s that with increased collagen breakdown, there is also
ncreased but dysfunctional cross-linking, which results in
igher overall levels of collagen but a pathological unsound
orm of collagen. The breakdown of collagen depends on a
omplex balance between matrix metalloproteinases
MMPs) and the tissue inhibitors of the metalloproteinases,
mong other factors (10). Previous work has shown mark-
dly abnormal MMP levels within AAAs (11).
Initial studies of the association between collagen break-
own products and AAA rupture focused on serum levels,
hich are easy to measure. To date, however, only weak
orrelations have been reported (12). Part of the problem
ay be that these circulating biomarkers are nonspecific and
ay be clouded by other processes, particularly atheroscle-
osis. Direct assessment of specific regions of the vessel wall
s preferable. With recent developments in molecular imag-
ng, wall-specific pathological processes can now be imaged.
Increased metabolic activity, as measured by using 18F-
uorodeoxyglucose positron emission tomography, has been
ssociated with acute symptoms and with high wall stress in
AAs (13,14). Molecular agents that target specific path-
logical pathways have shown promise in animal models of
AAs. Quantification of macrophage content within the
neurysm wall has been performed (15); macrophages along
ith other inflammatory markers are known to secrete
MPs and alter collagen metabolism. In vivo imaging of
MP expression has been performed, although not applied
n AAAs (16–18). Imaging MMPs alone is likely to be
imited because it discounts other aspects of collagen break-
own, such as tissue inhibitors of the metalloproteinases and
ther interrelated proteins.
The study by Klink et al. (19) in this issue of the Journal
easures collagen content in the wall of AAAs in mice
sing a collagen-specific gadolinium-labeled lipid micelle.
he collagen specificity is provided by CNA-35, a protein
orrowed from Staphylococcus aureus and thought to play a
ole in wound virulence. In their animal model, the inves-
igators found an association between decreased collagen
ontent and increased risk of rupture. This finding, if
urther validated, would make collagen imaging an impor-
ant component of the clinical risk-stratification of AAAs.
ollagen has been imaged previously using gadolinium-
abeled and single-photon emission computed tomography
gents (20,21), but these approaches used single moiety
gents for collagen binding. One of the main benefits of
sing a micelle in the imaging of collagen, as done by
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same molecule increases the binding strength to collagen.
The main drawback is that due to its larger size, a healthy
endothelium will prevent the micelle from entering the
vessel media (23).
Imaging has advanced to the point where the old para-
digm for risk-stratifying patients with AAAs using simple
anatomic considerations is soon to be outdated. Molecular
imaging not only allows direct imaging of vessel wall
inflammation but also of specific matrix proteins and path-
ological pathways. Collagen imaging is one of many new
developments that may allow better clinical management of
patients with AAAs.
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